Purchase Order 75F40123P00217
Award Date
7/18/23
Potential Completion Date
12/8/23
Potential Value
$88K
Federal Agency
Food and Drug Administration
Awardee
Olink Proteomics Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
B504 - Special Studies/Analysis- Chemical/Biological
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02453, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $79,345.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract is for quantitative proteomics measurement of human COVID-19 plasma samples, which supports the FDA's research efforts related to the COVID-19 pandemic. Olink Proteomics specializes in protein biomarker discovery and has provided a range of proteomics instruments, reagents, and analysis services to various...
This contract was awarded by the Department of Health and Human Services Food and Drug Administration to Olink Proteomics AB, a foreign-owned for-profit company, to provide proteomics analysis of plasma samples. The award, valued at $157,028.00, is a Firm Fixed Price purchase order with an August 2020 completion date. Olink Proteomics specializes in multiplex protein biomarker analysis technologies and has provided similar services to agencies like the National Institutes of Health and...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed price purchase order contract to Olink Proteomics Inc. for $115,920.00 to provide protein biomarker analysis of cardiotoxicity in human plasma samples. The contract has a completion date of December 31, 2022 and was awarded on June 9, 2022. No set-aside designation was used for this award. Olink Proteomics is a biotechnology company that specializes in proteomics solutions and has held...
The Food and Drug Administration (FDA) awarded a $94,500 firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned manufacturer of protein biomarker analysis technologies and services. The contract is for quantitative proteomics measurement of cardiotoxicity biomarkers in 150 human plasma samples using Olink's proprietary Explore 1536 multiplex analysis platform. This purchase order was awarded without a set-aside and is not associated with a larger contract vehicle. Olink...
The U.S. Food and Drug Administration (FDA) awarded a $99,413.00 firm-fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, to conduct cardiotoxicity biomarker analysis on plasma samples from cancer patients. The contract has an ultimate completion date of September 29, 2025. This contract was awarded under a competitive solicitation that was set aside for small businesses under NAICS code 541380 - Testing Laboratories and Services....
The Department of Health and Human Services Food and Drug Administration awarded a $40,000 firm fixed price delivery order against its IDIQ contract for Proteomics of Human Plasma and/or Serum. Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., will provide plasma proteomic assay services per sample under the terms of this order. Performance will take place in Silver Spring, Maryland through August 31, 2022. No set-aside designation was applied to this award made in...
This task order, awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA), calls for $470,000 in proteomics analysis services of human serum or plasma from Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The firm fixed price delivery order has a period of performance through August 31, 2022 and was awarded on September 30, 2020 without a set-aside designation. The place of performance will be Silver Spring, Maryland, where the HHS...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $28,448.82 firm fixed price purchase order to Olink Proteomics Inc. of Waltham, Massachusetts. The contract calls for Olink to provide reagents needed by the Critical Care Medicine Department to support the agency's biomedical research efforts. Performance will take place in Waltham through September 2023. No set aside designation or subcontractors were indicated. This purchase order utilizes...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Olink Proteomics Inc., a foreign-owned for-profit organization, in the amount of $113,936.00. The award is for the delivery of Olink's integrated fluidic circuits and reagent kits to support the Viral Pathogenesis and Evolution Section's research into the development of universal influenza and SARS-CoV-2 vaccines. The...
This is a $147,501.31 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract, which has no set-aside designation, is for the acquisition of Olink's O-Link System and reagents. Olink Proteomics specializes in protein biomarker discovery solutions and has provided a variety of proteomics instruments, assay kits, and analysis services to support government research efforts,...